The U.S. Centers for Disease Control and Prevention approved a new COVID-19 booster shot yesterday that targets the recently circulating BA.4 and BA.5 subvariants. The new Pfizer-BioNTech booster is available for anyone age 12 or older, while Moderna's ...
VIEW MORE : https://bit.ly/1breakingnews
